J. Reuben

Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts.

J. Reuben, M. Cristofanilli, R. Saldova, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system

V. Valero, S. Krishnamurthy, J. Reuben, 2012, International journal of cancer.

Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.

G. Hortobagyi, V. Valero, E. Rohren, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits.

D. Esseltine, J. Stec, G. Hortobagyi, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancer

J. Šufliarský, J. Reuben, M. Cristofanilli, 2016, BMC Cancer.

Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations.

G. Hortobagyi, L. Pusztai, V. Valero, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy.

G. Hortobagyi, V. Valero, A. Giordano, 2012 .